A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point
Summary
A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point is a scholarly article[1].
Key Facts
A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point. Retrieved May 24, 2026, from https://4ort.xyz/entity/a-utility-based-bayesian-phase-iii-design-for-immunotherapy-trials-with-progression-free-survival-end-point
MLA“A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/a-utility-based-bayesian-phase-iii-design-for-immunotherapy-trials-with-progression-free-survival-end-point.
BibTeX@misc{4ortxyz_a-utility-based-bayesian-phase-iii-design-for-immunotherapy-trials-with-progression-free-survival-end-point_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point}}, year = {2026}, url = {https://4ort.xyz/entity/a-utility-based-bayesian-phase-iii-design-for-immunotherapy-trials-with-progression-free-survival-end-point}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point — https://4ort.xyz/entity/a-utility-based-bayesian-phase-iii-design-for-immunotherapy-trials-with-progression-free-survival-end-point (retrieved 2026-05-24)
